Importance

Loading Importance Indicators...

Abstract

The product comprises a colloidal suspension which includes the ingredients liposomal adenosine triphosphate salt (liposomal ATP), methylcobalamin, glutathione, liposomal curcumin, liposomal resveratrol, taurine, fulvic acid, and acetyl L-carnitine, which will be delivered intravenously or by other parenteral means for the treatment of traumatic brain injury. Published studies indicate these substances, tested individually, reduce neuroinflammation or other secondary pathologies caused by a brain injury. Combination of the substances into a single intravenous colloidal suspension offers significant potential to directly reduce oxidative damage and directly improve the brain's energy crisis caused by traumatic brain injury (TBI), thereby mitigating the pathophysiological cascade of secondary damage after TBI. The product will be modified by removing glutathione for patients with a history of autoimmune disorders Stevens-Johnson syndrome or toxic epidermal necrolysis. Precise dosages of liposomal ATP, liposomal curcumin, liposomal resveratrol, taurine, and fulvic acid will be determined by various laboratory and medical tests explained in other sections of the application.

Loading the Abstract Image...

First Claim